63 - Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/0c/e4/6b/0ce46b91-3d22-279b-52fe-d3b1a2a47107/mza_11625791986367831883.jpg/600x600bb.jpg

TMO EPM / Hemato H9J

64 episodes

4 days ago

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA

Medicine

Health & Fitness

RSS

All content for TMO EPM / Hemato H9J is the property of TMO EPM / Hemato H9J and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Podcast de discussão de assuntos em Hematologia do Transplante de Medula Óssea da Escola Paulista de Medicina (UNIFESP) e da Hematologia do Hospital 9 de Julho - DASA

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/38086306/38086306-1756757285040-e691706836d42.jpg

63 - Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT

TMO EPM / Hemato H9J

21 minutes 57 seconds

2 months ago

63 - Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT

Discussão do artigo: "Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT" de DeFilipp Blood 2025

Apresentado por: Dra. Amanda Chucre

Discussão por: Dr. Eduardo Burlamaqui, Dr. Matheus Garcia, Dr. Pedro Moraes e Dr. Vinícius Molla